Oxygen consumption by cultured human cells is impaired by a nucleoside analogue cocktail that inhibits mitochondrial DNA synthesis

Mitochondrion

Volumn 5, Issue 3, 2005, Pages 154-161

  Petit, Caroline ^a   Piétri Rouxel, France ^a   Lesne, Annick ^b   Leste Lasserre, Thierry ^a   Mathez, Dominique ^c   Naviaux, Robert K ^d   Sonigo, Pierre ^a   Bouillaud, Frédéric ^e   Leibowitch, Jacques ^c  

^a INSTITUT COCHIN   (France)

^b UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d INSERM   (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human cells; Mitochondrial DNA; Nucleoside reverse transcriptase inhibitors; Oxygen consumption

Indexed keywords

ANTIRETROVIRUS AGENT; MITOCHONDRIAL DNA; NUCLEOSIDE ANALOG; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

ADIPOSE TISSUE; ARTICLE; CELL CULTURE; CELL METABOLISM; CELL PROLIFERATION; DNA SYNTHESIS INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIPID STORAGE; LIPODYSTROPHY; LYMPHOID CELL LINE; MITOCHONDRIAL DNA REPLICATION; MITOCHONDRIAL RESPIRATION; ONLINE MONITORING; OXYGEN CONSUMPTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOCYTES; CELL CULTURE TECHNIQUES; CELL LINE; CELL RESPIRATION; DNA, MITOCHONDRIAL; HUMANS; LIPIDS; MODELS, BIOLOGICAL; OXYGEN CONSUMPTION; REVERSE TRANSCRIPTASE INHIBITORS; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

EID: 20644451601     PISSN: 15677249     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mito.2004.09.004     Document Type: Article

References (20)

1. K. Brinkman H.J. ter Hofstede D.M. Burger J.A. Smeitink P.P. Koopmans Adverse effects of reverse transcriptase inhibitors: Mitochondrial toxicity as common pathway Aids 12 1998 1735-1744
2. K. Brinkman J.A. Smeitink J.A. Romijn P. Reiss Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy Lancet 354 1999 1112-1115
3. A. Carr K. Samaras A. Thorisdottir G.R. Kaufmann D.J. Chisholm D.A. Cooper Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study Lancet 353 1999 2093-2099
4. G. Chene E. Angelini L. Cotte J.M. Lang P. Morlat C. Rancinan T. May V. Journot F. Raffi B. Jarrousse M. Grappin G. Lepeu J.M. Molina Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients Clin. Infect Dis. 34 2002 649-657
5. B. Fromenty D. Pessayre Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity Pharmacol. Ther. 67 1995 101-154
6. F.N. Gellerich M. Deschauer Y. Chen T. Muller S. Neudecker S. Zierz Mitochondrial respiratory rates and activities of respiratory chain complexes correlate linearly with heteroplasmy of deleted mtDNA without threshold and independently of deletion size Biochim. Biophys. Acta. 1556 2002 41-52
7. U. Hazan I.A. Romero R. Cancello S. Valente V. Perrin V. Mariot J. Dumonceaux C.C. Gerhardt A.D. Strosberg P.O. Couraud F. Pietri-Rouxel Human adipose cells express CD4, CXCR4, and CCR5 [corrected] receptors: a new target cell type for the immunodeficiency virus-1? Faseb. J. 16 2002 1254-1256
8. A.A. Johnson A.S. Ray J. Hanes Z. Suo J.M. Colacino K.S. Anderson K.A. Johnson Toxicity of antiviral nucleoside analogs and the human mitochondrial DNA polymerase J. Biol. Chem. 276 2001 40847-40857
9. T.N. Kakuda Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity Clin. Ther. 22 2000 685-708
10. W. Lewis M.C. Dalakas Mitochondrial toxicity of antiviral drugs Nat. Med. 1 1995 417-422
11. M.J. Longley P.A. Ropp S.E. Lim W.C. Copeland Characterization of the native and recombinant catalytic subunit of human DNA polymerase gamma: identification of residues critical for exonuclease activity and dideoxynucleotide sensitivity Biochemistry 37 1998 10529-10539
12. J.L. Martin C.E. Brown N. Matthews-Davis J.E. Reardon Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis Antimicrob. Agents Chemother. 38 1994 2743-2749
13. J.M. Molina G. Chene F. Ferchal V. Journot I. Pellegrin M.N. Sombardier C. Rancinan L. Cotte I. Madelaine T. Debord J.M. Decazes The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus J. Infect. Dis. 180 1999 351-358
14. A. Munoz-Malaga J. Bautista J.A. Salazar I. Aguilera R. Garcia I. Chinchon M.D. Segura Y. Campos J. Arenas Lipomatosis, proximal myopathy, and the mitochondrial 8344 mutation. A lipid storage myopathy? Muscle Nerve 23 2000 538-542
15. D. Nolan E. Hammond A. Martin L. Taylor S. Herrmann E. McKinnon C. Metcalf B. Latham S. Mallal Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy Aids 17 2003 1329-1338
16. C. Petit D. Mathez C. Barthelemy T. Leste-Lasserre R.K. Naviaux P. Sonigo J. Leibowitch Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion J. Acquir. Immune Defic. Syndr. 33 2003 461-469
17. R. Rossignol B. Faustin C. Rocher M. Malgat J.P. Mazat T. Letellier Mitochondrial threshold effects Biochem. J. 370 2003 751-762
18. C.M. Shikuma N. Hu C. Milne F. Yost C. Waslien S. Shimizu B. Shiramizu Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV- infected individuals with peripheral lipoatrophy Aids 15 2001 1801-1809
19. K.E. Squires An introduction to nucleoside and nucleotide analogues Antivir. Ther. 6 Suppl. 3 2001 1-14
20. U.A. Walker M. Bickel S.I. Lutke Volksbeck U.P. Ketelsen H. Schofer B. Setzer N. Venhoff V. Rickerts S. Staszewski Evidence of nucleoside analogue reverse transcriptase inhibitor- associated genetic and structural defects of mitochondria in adipose tissue of HIV-infected patients J. Acquir. Immune Defic. Syndr. 29 2002 117-121